Publications

Journal Article Ppublish 33 citations
Electronic publication date
February 14, 2014

View on Pubmed.gov 22527847 | View on doi.org 10.1007/s10147-...

Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer.

Search for publications in this journal Int J Clin Oncol - 18(3):478-86

  • Yi Kang

    Search for this expert
    1
  • Jiancheng Zhang

    Search for this expert
  • Peichun Sun

    Search for this expert
  • Jia Shang

Abstract

BACKGROUND

Our aims were to detect circulating cell-free human telomerase reverse transcriptase (hTERT) mRNA in the plasma of gastric cancer patients and evaluate its potential diagnostic and prognostic value.

METHODS

Real-time quantitative reverse transcription-polymerase chain reaction was employed to detect circulating cell-free hTERT mRNA from 118 gastric cancer patients, 40 chronic atrophic gastritis (CAG) patients, and 58 healthy controls.

RESULTS

Circulating cell-free hTERT mRNA was detected in all gastric cancer patients, 39 (97.5 %) CAG patients and 56 (96.6 %) healthy control individuals, respectively. However, it was higher in gastric cancer than in CAG and healthy controls (all at P < 0.05). Moreover, its high level was significantly correlated with clinical stages (P < 0.001) and lymph nodes metastasis (P < 0.001). There was no difference between circulating cell-free mRNA and other parameters. The area under the receiver operating characteristic (ROC) curve was 0.891, and the optimal cut-off point was 0.18, providing a sensitivity of 66 % and a specificity of 87 %. The ROC analysis showed that the diagnosis capability of circulating cell-free mRNA was statistically significantly higher than that of carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9), alone [CEA (0.656); CA19-9 (0.722)] or in combination (0.756). Kaplan-Meier analysis demonstrated a correlation between increased circulating cell-free hTERT mRNA and reduced disease-free survival (P < 0.001) and overall survival (P < 0.001). Cox analysis indicated that it was an independent prognostic factor for disease-free survival and overall survival.

CONCLUSIONS

We concluded that circulating cell-free hTERT mRNA might serve as a potential and useful noninvasive tumor marker for gastric cancer.

References

Clin Cancer Res. 2009 Nov 15;15(22):6810-9

Mod Pathol. 2003 Jul;16(7):700-7

Nat Rev Cancer. 2011 Jun;11(6):426-37

Clin Cancer Res. 2000 Oct;6(10):3823-6

Cited by 33 citations (total)

Journal Article Review

Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches.

Electronic publication date March 11, 2020

Search for publications in this journal Cancers (Basel)

Aravind Sanjeevaiah [...] Matthew Porembka et al.

Gastric adenocarcinoma is an aggressive cancer that demonstrates heterogeneous biology depending on patient ethnicity, tumor location, tumor type, and genetic...

Journal Article

Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Electronic publication date July 31, 2012

Search for publications in this journal World J Gastrointest Oncol

Siddavaram Nagini

Carcinoma of the stomach is still the second most common cause of cancer death worldwide, although the incidence and mortality...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances